Larynx Cancer Clinical Trial
— TritubeOfficial title:
Sammenligning Mellem Standard Tube og Den Ultra-tynde Tritube® Til Intubation, og Til Opretholdelse af Adgang Til Trachea Efter anæstesi, Hos Patienter Med Forventet Vanskelig Direkte Laryngoskopi
Verified date | February 2024 |
Source | Rigshospitalet, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators compare the ease of intubation between a new ultra-thin endotracheal tube, "Tritube", and a standard endotracheal tube in patients with predictors of difficult laryngoscopy. Furthermore the investigators compare the acceptance of leaving the Tritube in trachea after end of anaesthesia, with the use of a tube exchange catheter.
Status | Completed |
Enrollment | 48 |
Est. completion date | February 14, 2019 |
Est. primary completion date | February 14, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients for anaesthesia for surgery in the Head-/neck/ear/nose/throat - planned for oral intubation with video-laryngoscopy - with risk factors for difficult direct laryngoscopy Exclusion Criteria: - Patient with increased secretions in the airway (Pneumonia, bronchitis, productive cough) - Patients planned for awake intubation - Patients where mask-ventilation is judged to could become impossible - Patients where access to the cricothyroid membrane is judged to be difficult or impossible - Patients in ASA (american Society of Anaesthesiologists) physical classification status >3 - Patients who are scheduled for rapid sequence induction (RSI) due to risk of aspiration - Patients with stridor - Patients with hypoxemia (Saturation < 90 % in room air) - Operation duration planned to > 2.5 hours - Patients with the need for a nerve-stimulation-tube during surgery |
Country | Name | City | State |
---|---|---|---|
Denmark | Rigshospitalet, section for anaesthesia for ENT and Maxillofacial surgery, section 3071 | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Michael Seltz Kristensen |
Denmark,
Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J; 8th International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007 Aug;51(7):789-808. doi: 10.1111/j.1399-6576.2007.01352.x. — View Citation
Kristensen MS, de Wolf MWP, Rasmussen LS. Ventilation via the 2.4 mm internal diameter Tritube(R) with cuff - new possibilities in airway management. Acta Anaesthesiol Scand. 2017 Jul;61(6):580-589. doi: 10.1111/aas.12894. Epub 2017 Apr 23. — View Citation
Strom C, Barnung S, Kristensen MS, Bottger M, Tvede MF, Rasmussen LS. Tracheal intubation in patients with anticipated difficult airway using Boedeker intubation forceps and McGrath videolaryngoscope. Acta Anaesthesiol Scand. 2015 Oct;59(9):1154-60. doi: 10.1111/aas.12543. Epub 2015 May 16. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of Excellent intubation conditions | Rate of Excellent intubation conditions judged on the scale excellent/good/fair/poor | 2 hours | |
Secondary | The rate of interruption by the tube of the view to the vocal cords at any time, to such a degree that it disturbs the intubation | 2 hours | ||
Secondary | The Intubation Difficulty Score (IDS) | The intubation difficulty scale , range 0 to 7, 0 indicates easy intubation, 1 - 5 indicates slight difficulty, 5< indicates moderate to major difficulty | 2 hours | |
Secondary | Time to intubated | Time from the tube is advanced past the vocal cords until the cuff is inflated in the trachea | 2 hours | |
Secondary | Time to the patient becomes ventilated via the tube | Time from the tube is advanced past the vocal cords until the cuff is inflated in the trachea and CO2 waveform is observed | 2 hours | |
Secondary | Number of intubation attempts | one attempt is every-time the tube is advanced past the incisors | 2 hours | |
Secondary | The rate of succesful intubation with 60 seconds | 1 minute | ||
Secondary | Number of remodellings of the stilette | 2 hours | ||
Secondary | rate of use for "reverse loading" of the tube on the stylet | 2 hours | ||
Secondary | the "percent of glottic opening" , (POGO), Before the tube is inserted | 2 hours | ||
Secondary | the"percent of glottic opening" , POGO, with the tube in place | 2 hors | ||
Secondary | Intubation conditions Strom scale | Direction of the tube-stylet combination excellent/good/poor, easy/fair/difficult. Advancement of the tube-stylet combination excellent/good/poor easy/fair/difficult | 2 hours | |
Secondary | The surgeons score of the space and working conditions in the mouth/pharynx and larynx after intubation | 2 hours | ||
Secondary | The difference between ET CO2 and arterial blood-gas CO2 after 15 minutes of surgery | 20 minutes | ||
Secondary | the duration of the Tritube being in the trachea after return of spontaneous ventilation and deflation of the cuff /(Tritube group) | 4 hours | ||
Secondary | The duration of the tube-exchange catheter being in the trachea after its placement / (Tube-exchange-catheter group) | 4 hours | ||
Secondary | The ration of patients who still has the Tritube or the tube-exchange-catheter in place when arriving in the post-operative recovery unit | 4 hours | ||
Secondary | The ration of patients who still has the Tritube or the tube-exchange-catheter in place one hour after arrival in the Post anaesthesia care unit the post-operative recovery unit | 4 hours | ||
Secondary | The patient's satisfaction with having the Tritube or the tube-exchange-catheter in place when being awake in the Post anaesthesia care unit | Visual analog scale from 1-10, 1= no nuisance, 10= unberable | 4 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
Completed |
NCT03292341 -
Evaluation of a Web-based Decision Aid Tool for Larynx Cancer (T3/T4) Patients.
|
N/A | |
Completed |
NCT05746780 -
Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
|
||
Recruiting |
NCT05793151 -
Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy
|
N/A | |
Completed |
NCT01700647 -
Breath Testing in Early and Late Larynx Cancer
|
N/A | |
Completed |
NCT00600223 -
Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Construction Approaches
|
N/A | |
Completed |
NCT00169247 -
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
|
Phase 2 | |
Recruiting |
NCT03759431 -
Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02586207 -
Pembrolizumab in Combination With CRT for LA-SCCHN
|
Phase 1 | |
Recruiting |
NCT04057209 -
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
|
N/A | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Recruiting |
NCT06086119 -
Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers
|
||
Suspended |
NCT04368702 -
CONFIRM: Magnetic Resonance Guided Radiation Therapy
|
N/A | |
Completed |
NCT05217147 -
An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma
|
||
Active, not recruiting |
NCT03082534 -
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT00158652 -
Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC
|
Phase 3 | |
Terminated |
NCT03479463 -
Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
|
||
Completed |
NCT03096808 -
Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 2 | |
Completed |
NCT03028766 -
WEE1 Inhibitor With Cisplatin and Radiotherapy: A Trial in Head and Neck Cancer
|
Phase 1 | |
Completed |
NCT00359645 -
Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
|
Phase 3 |